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A 33-year-old woman who works as a yoga teacher and 
lived in the city of Rio de Janeiro (RJ) - Brazil, sought 
ophthalmologic care at a routine examination. She did 
not report comorbidities and previous or regular use 
of medicines of any type. At examination the patient 
had good corrected visual acuity of 20/20 in both eyes. 
Biomicroscopy showed bilateral corneal verticillata, 
and in the rest of examination no other abnormalities 
were seen. 
Fabry disease is hereditary and X-chromosome 
linked. This disease is caused by deficiency of the 
enzyme α-galactosidase A that leads to progressive 
accumulation of lipid substances in the interior of the 
endothelium and smooth muscles of blood vessels so 
that affecting several organs.(1) Men are more affected 
by Fabry disease because they had the X chromosome 
Figure 1. Biomicroscopy showing the corneal verticillata
to codify the enzyme α-galactosidase. Heterozygote 
women are commonly the carriers of the Fabry gene 
(GLA gene, the only gene identified so far), which 
present a random activity of the enzyme α-galactosidase 
A that turns its dosage less reliable for the diagnosis. 
The genetic molecular test is the most reliable diagnostic 
method for Fabry in female carrier.(1)
Angiokeratoma, acroparesthesia, hypertrophic 
cardiomyopathy, anhidrosis and corneal verticillata 
are common features of Fabry disease. The disease’s 
clinical course is heterogeneous and variable especially 
in women.(2,3) 
Corneal verticillata was the most found ophthalmology 
change in men an women with Fabry disease. It presents 
an incidence of 76.9% in men and 73.1% in women and 
was describe almost as pathognomonic.(2,3) Initial lesion 
einstein. 2014;12(4):527-8
528 Costa AL, Roisman V, Martins TG
observed in cornea is diffuse subepithelial layer opacity 
that progressively adopt a verticillata appearance.(1) This 
appearance could be an isolated finding without other 
ocular abnormalities.(2) Overall, there is no impair in 
vision associated with this corneal alteration.(3)
The Fabry disease along with amiodarone therapy is 
the most common cause of this form of corneal opacity, 
and the simple history assessment of medication used 
by the patient helps to clarify the cause.(4)
The patient blood sample was sent to a Germany 
laboratory for molecular genetic test to confirm the 
diagnosis of Fabry disease. Our patient was probably 
heterozygote for Fabry disease because, up to the time 
of examination, she did not have any symptom of the 
disease expected the corneal alteration. However, in this 
case, the ophthalmologic investigation was essential 
to establish the diagnosis and give the patient the 
opportunity to understand risks and care needed to all 
sufferers of this rare condition. 
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